Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ifabric Corp (TSX: IFA )

1.250 UNCHANGED
Streaming Delayed Price Updated: 12:01 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.250
Bid (Size) 1.190 (15)
Ask (Size) 1.250 (1)
Prev. Close 1.250
Today's Range 1.250 - 1.250
52wk Range 0.8700 - 1.740
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
iFabric Corp Announces Record Revenues and Earnings for Q1 2024
Via ACCESSWIRE
iFabric Corp. Receives FDA Medical Device Registration for Apparel Products Utilizing Multiple Textile Technologies
Via ACCESSWIRE

Performance

YTD
+8.70%
+8.70%
1 Month
+5.93%
+5.93%
3 Month
+23.76%
+23.76%
6 Month
+3.31%
+3.31%
1 Year
-7.41%
-7.41%

More News

Read More
iFabric Corp. Announces US EPA Registration of TWO New Cutting-Edge Antimicrobial Technologies
Via ACCESSWIRE
iFabric Corp Reports Increased Revenues for Its Financial Period Ended December 31, 2023
Via ACCESSWIRE
iFabric Corp. Provides Revenue Forecast for Fiscal 2024, Driven by Additional Customer Programs and New Performance-Apparel Categories
Via ACCESSWIRE
iFabric Corp Announces Q1 2023 Financial Results
Via ACCESSWIRE
iFabric Corp Reports Record 3rd Quarter Revenues
Via ACCESSWIRE
iFabric Corp Reports Record Annual Revenues for its Financial Period Ended September 30, 2023
Via ACCESSWIRE
iFabric Corp Announces Expansion Move
Via ACCESSWIRE
iFabric Corp Announces Maidenform(R) License Renewal
Via ACCESSWIRE
iFabric Corp Update on Status of EPA Submission of PROTX2 Textile Application
Via ACCESSWIRE
iFabric Corp Matches Record Revenues of $5.3 Million for Q3 2023
Via ACCESSWIRE
iFabric Corp Announces the Successful Results of the Clinical Trial Utilizing Protx2 Treated Scrubs
Via ACCESSWIRE
iFabric Corp Announces Issuance of New United States Utility Patent for Antiviral Applications on Textiles
Via ACCESSWIRE
iFabric Corp Reports a Record 91% Increase in Second Quarter Revenues
Via ACCESSWIRE
iFabric Corp Announces Breakthrough in EPA Public Health Claims Approval Process With Initial Registration of PROTX2 for Use in Non-Apparel Products
Via ACCESSWIRE
iFabric Corp Announces Exclusive License Agreement with Les Innovation Simon Chang
Via ACCESSWIRE
iFabric Corp Announces EPA Registration of New Technology, bioACTIV AM
Via ACCESSWIRE
iFabric Corp Reports Revenues and Earnings for Its Financial Year Ended September 30, 2022
Via ACCESSWIRE
iFabric Corp Announces Launch of "Verzus All" Apparel Brand and New Orders
Via ACCESSWIRE
iFabric Corp Updates on Clinical Trial for Treated Medical Scrubs
Via ACCESSWIRE
iFabric Corp Updates on Clinical Trial for Treated Medical Scrubs
From iFabric Corp
Via AccessWire
iFabric Corp Signs New Agreement with The North Face
From iFabric Corp
Via AccessWire
iFabric Announces License Agreement With Roots Corporation
From iFabric Corp
Via AccessWire
iFabric Corp Reports a 21% Revenue Increase in Its Second Quarter Ended March 31, 2022
From iFabric Corp
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.